Global Follicle Stimulating Hormone Market Insights and Forecast to 2027

Global Follicle Stimulating Hormone Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Follicle Stimulating Hormone Product Introduction
1.2 Market by Type
1.2.1 Global Follicle Stimulating Hormone Market Size Growth Rate by Type
1.4.2 Recombinant FSH
1.4.3 Urinary FSH
1.3 Market by Application
1.3.1 Global Follicle Stimulating Hormone Market Size Growth Rate by Application
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Follicle Stimulating Hormone Sales Estimates and Forecasts 2016-2027
2.2 Global Follicle Stimulating Hormone Revenue Estimates and Forecasts 2016-2027
2.3 Global Follicle Stimulating Hormone Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Follicle Stimulating Hormone Regions by Sales
2.4.1 Global Top Follicle Stimulating Hormone Regions by Sales (2016-2021)
2.4.2 Global Top Follicle Stimulating Hormone Regions by Sales (2022-2027)
2.5 Global Top Follicle Stimulating Hormone Regions by Revenue
2.5.1 Global Top Follicle Stimulating Hormone Regions by Revenue (2016-2021)
2.5.2 Global Top Follicle Stimulating Hormone Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Follicle Stimulating Hormone Sales by Manufacturers
3.1.1 Global Top Follicle Stimulating Hormone Manufacturers by Sales (2016-2021)
3.1.2 Global Top Follicle Stimulating Hormone Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Follicle Stimulating Hormone Sales in 2020
3.2 Global Follicle Stimulating Hormone Revenue by Manufacturers
3.2.1 Global Top Follicle Stimulating Hormone Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Follicle Stimulating Hormone Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Follicle Stimulating Hormone Revenue in 2020
3.3 Global Follicle Stimulating Hormone Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Follicle Stimulating Hormone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Follicle Stimulating Hormone Sales by Type
4.1.1 Global Follicle Stimulating Hormone Historical Sales by Type (2016-2021)
4.1.2 Global Follicle Stimulating Hormone Forecasted Sales by Type (2022-2027)
4.1.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
4.2 Global Follicle Stimulating Hormone Revenue by Type
4.2.1 Global Follicle Stimulating Hormone Historical Revenue by Type (2016-2021)
4.2.2 Global Follicle Stimulating Hormone Forecasted Revenue by Type (2022-2027)
4.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
4.3 Global Follicle Stimulating Hormone Price by Type
4.3.1 Global Follicle Stimulating Hormone Price by Type (2016-2021)
4.3.2 Global Follicle Stimulating Hormone Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Follicle Stimulating Hormone Sales by Application
5.1.1 Global Follicle Stimulating Hormone Historical Sales by Application (2016-2021)
5.1.2 Global Follicle Stimulating Hormone Forecasted Sales by Application (2022-2027)
5.1.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
5.2 Global Follicle Stimulating Hormone Revenue by Application
5.2.1 Global Follicle Stimulating Hormone Historical Revenue by Application (2016-2021)
5.2.2 Global Follicle Stimulating Hormone Forecasted Revenue by Application (2022-2027)
5.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
5.3 Global Follicle Stimulating Hormone Price by Application
5.3.1 Global Follicle Stimulating Hormone Price by Application (2016-2021)
5.3.2 Global Follicle Stimulating Hormone Price Forecast by Application (2022-2027)
6 North America
6.1 North America Follicle Stimulating Hormone Market Size by Type
6.1.1 North America Follicle Stimulating Hormone Sales by Type (2016-2027)
6.1.2 North America Follicle Stimulating Hormone Revenue by Type (2016-2027)
6.2 North America Follicle Stimulating Hormone Market Size by Application
6.2.1 North America Follicle Stimulating Hormone Sales by Application (2016-2027)
6.2.2 North America Follicle Stimulating Hormone Revenue by Application (2016-2027)
6.3 North America Follicle Stimulating Hormone Market Size by Country
6.3.1 North America Follicle Stimulating Hormone Sales by Country (2016-2027)
6.3.2 North America Follicle Stimulating Hormone Revenue by Country (2016-2027)
7 Europe
7.1 Europe Follicle Stimulating Hormone Market Size by Type
7.1.1 Europe Follicle Stimulating Hormone Sales by Type (2017-2027)
7.1.2 Europe Follicle Stimulating Hormone Revenue by Type (2017-2027)
7.2 Europe Follicle Stimulating Hormone Market Size by Application
7.2.1 Europe Follicle Stimulating Hormone Sales by Application (2017-2027)
7.2.2 Europe Follicle Stimulating Hormone Revenue by Application (2017-2027)
7.3 Europe Follicle Stimulating Hormone Market Size by Country
7.3.1 Europe Follicle Stimulating Hormone Sales by Country (2017-2027)
7.3.2 Europe Follicle Stimulating Hormone Revenue by Country (2017-2027)
7.3.3 Poland
8 Asia Pacific
8.1 Asia Pacific Follicle Stimulating Hormone Market Size by Type
8.1.1 Asia Pacific Follicle Stimulating Hormone Sales by Type (2018-2027)
8.1.2 Asia Pacific Follicle Stimulating Hormone Revenue by Type (2018-2027)
8.2 Asia Pacific Follicle Stimulating Hormone Market Size by Application
8.2.1 Asia Pacific Follicle Stimulating Hormone Sales by Application (2018-2027)
8.2.2 Asia Pacific Follicle Stimulating Hormone Revenue by Application (2018-2027)
8.3 Asia Pacific Follicle Stimulating Hormone Market Size by Region
8.3.1 Asia Pacific Follicle Stimulating Hormone Sales by Region (2018-2027)
8.3.2 Asia Pacific Follicle Stimulating Hormone Revenue by Region (2018-2027)
9 Latin America
9.1 Latin America Follicle Stimulating Hormone Market Size by Type
9.1.1 Latin America Follicle Stimulating Hormone Sales by Type (2019-2027)
9.1.2 Latin America Follicle Stimulating Hormone Revenue by Type (2019-2027)
9.2 Latin America Follicle Stimulating Hormone Market Size by Application
9.2.1 Latin America Follicle Stimulating Hormone Sales by Application (2019-2027)
9.2.2 Latin America Follicle Stimulating Hormone Revenue by Application (2019-2027)
9.3 Latin America Follicle Stimulating Hormone Market Size by Country
9.3.1 Latin America Follicle Stimulating Hormone Sales by Country (2019-2027)
9.3.2 Latin America Follicle Stimulating Hormone Revenue by Country (2019-2027)
6 Middle East and Africa
6.1 Middle East and Africa Follicle Stimulating Hormone Market Size by Type
6.1.1 Middle East and Africa Follicle Stimulating Hormone Sales by Type (2016-2027)
6.1.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2016-2027)
6.2 Middle East and Africa Follicle Stimulating Hormone Market Size by Application
6.2.1 Middle East and Africa Follicle Stimulating Hormone Sales by Application (2016-2027)
6.2.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2016-2027)
6.3 Middle East and Africa Follicle Stimulating Hormone Market Size by Country
6.3.1 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2016-2027)
6.3.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2016-2027)
11 Company Profiles
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Overview
11.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Serono Follicle Stimulating Hormone Product Description
11.1.5 Merck Serono Related Developments
11.2 MSD
11.2.1 MSD Corporation Information
11.2.2 MSD Overview
11.2.3 MSD Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 MSD Follicle Stimulating Hormone Product Description
11.2.5 MSD Related Developments
11.3 IBSA
11.3.1 IBSA Corporation Information
11.3.2 IBSA Overview
11.3.3 IBSA Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 IBSA Follicle Stimulating Hormone Product Description
11.3.5 IBSA Related Developments
11.4 Ferring
11.4.1 Ferring Corporation Information
11.4.2 Ferring Overview
11.4.3 Ferring Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Ferring Follicle Stimulating Hormone Product Description
11.4.5 Ferring Related Developments
11.5 Livzon
11.5.1 Livzon Corporation Information
11.5.2 Livzon Overview
11.5.3 Livzon Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Livzon Follicle Stimulating Hormone Product Description
11.5.5 Livzon Related Developments
11.6 Techwell
11.6.1 Techwell Corporation Information
11.6.2 Techwell Overview
11.6.3 Techwell Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Techwell Follicle Stimulating Hormone Product Description
11.6.5 Techwell Related Developments
11.7 GenSci
11.7.1 GenSci Corporation Information
11.7.2 GenSci Overview
11.7.3 GenSci Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 GenSci Follicle Stimulating Hormone Product Description
11.7.5 GenSci Related Developments
11.8 Gedeon Richter
11.8.1 Gedeon Richter Corporation Information
11.8.2 Gedeon Richter Overview
11.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Gedeon Richter Follicle Stimulating Hormone Product Description
11.8.5 Gedeon Richter Related Developments
11.9 Teva
11.9.1 Teva Corporation Information
11.9.2 Teva Overview
11.9.3 Teva Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Teva Follicle Stimulating Hormone Product Description
11.9.5 Teva Related Developments
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Overview
11.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Serono Follicle Stimulating Hormone Product Description
11.1.5 Merck Serono Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Follicle Stimulating Hormone Value Chain Analysis
12.2 Follicle Stimulating Hormone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Follicle Stimulating Hormone Production Mode & Process
12.4 Follicle Stimulating Hormone Sales and Marketing
12.4.1 Follicle Stimulating Hormone Sales Channels
12.4.2 Follicle Stimulating Hormone Distributors
12.5 Follicle Stimulating Hormone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Follicle Stimulating Hormone Industry Trends
13.2 Follicle Stimulating Hormone Market Drivers
13.3 Follicle Stimulating Hormone Market Challenges
13.4 Follicle Stimulating Hormone Market Restraints
14 Key Findings in The Global Follicle Stimulating Hormone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Follicle Stimulating Hormone Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Recombinant FSH
Table 3. Major Manufacturers of Urinary FSH
Table 4. Global Follicle Stimulating Hormone Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Follicle Stimulating Hormone Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 7. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 8. Global Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 9. Global Follicle Stimulating Hormone Sales Market Share by Region (2022-2027)
Table 10. Global Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
Table 12. Global Follicle Stimulating Hormone Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Follicle Stimulating Hormone Revenue Market Share by Region (2022-2027)
Table 14. Global Follicle Stimulating Hormone Sales by Manufacturers (2016-2021) & (K Doses)
Table 15. Global Follicle Stimulating Hormone Sales Share by Manufacturers (2016-2021)
Table 16. Global Follicle Stimulating Hormone Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2016-2021)
Table 18. Follicle Stimulating Hormone Price by Manufacturers 2016-2021 (USD/Dose)
Table 19. Global Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2020)
Table 21. Follicle Stimulating Hormone Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Follicle Stimulating Hormone Product Offered
Table 23. Date of Manufacturers Enter into Follicle Stimulating Hormone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 26. Global Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 27. Global Follicle Stimulating Hormone Sales Share by Type (2016-2021)
Table 28. Global Follicle Stimulating Hormone Sales Share by Type (2022-2027)
Table 29. Global Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Follicle Stimulating Hormone Revenue Share by Type (2016-2021)
Table 32. Global Follicle Stimulating Hormone Revenue Share by Type (2022-2027)
Table 33. Follicle Stimulating Hormone Price by Type (2016-2021) & (USD/Dose)
Table 34. Global Follicle Stimulating Hormone Price Forecast by Type (2022-2027) & (USD/Dose)
Table 35. Global Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 36. Global Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 37. Global Follicle Stimulating Hormone Sales Share by Application (2016-2021)
Table 38. Global Follicle Stimulating Hormone Sales Share by Application (2022-2027)
Table 39. Global Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Follicle Stimulating Hormone Revenue Share by Application (2016-2021)
Table 42. Global Follicle Stimulating Hormone Revenue Share by Application (2022-2027)
Table 43. Follicle Stimulating Hormone Price by Application (2016-2021) & (USD/Dose)
Table 44. Global Follicle Stimulating Hormone Price Forecast by Application (2022-2027) & (USD/Dose)
Table 45. North America Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 46. North America Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 47. North America Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 50. North America Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 51. North America Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 54. North America Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 55. North America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Follicle Stimulating Hormone Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 58. Europe Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 59. Europe Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 62. Europe Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 63. Europe Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 66. Europe Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 67. Europe Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Follicle Stimulating Hormone Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 70. Asia Pacific Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 71. Asia Pacific Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 74. Asia Pacific Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 75. Asia Pacific Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 78. Asia Pacific Follicle Stimulating Hormone Sales by Region (2022-2027) & (K Doses)
Table 79. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 82. Latin America Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 83. Latin America Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 86. Latin America Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 87. Latin America Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 90. Latin America Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 91. Latin America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Follicle Stimulating Hormone Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 94. Middle East and Africa Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 95. Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Follicle Stimulating Hormone Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 98. Middle East and Africa Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 99. Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Follicle Stimulating Hormone Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 102. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 103. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2022-2027) & (US$ Million)
Table 105. Merck Serono Corporation Information
Table 106. Merck Serono Description and Major Businesses
Table 107. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. Merck Serono Follicle Stimulating Hormone Product
Table 109. Merck Serono Recent Developments
Table 110. MSD Corporation Information
Table 111. MSD Description and Major Businesses
Table 112. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. MSD Follicle Stimulating Hormone Product
Table 114. MSD Recent Developments
Table 115. IBSA Corporation Information
Table 116. IBSA Description and Major Businesses
Table 117. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. IBSA Follicle Stimulating Hormone Product
Table 119. IBSA Recent Developments
Table 120. Ferring Corporation Information
Table 121. Ferring Description and Major Businesses
Table 122. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Ferring Follicle Stimulating Hormone Product
Table 124. Ferring Recent Developments
Table 125. Livzon Corporation Information
Table 126. Livzon Description and Major Businesses
Table 127. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Livzon Follicle Stimulating Hormone Product
Table 129. Livzon Recent Developments
Table 130. Techwell Corporation Information
Table 131. Techwell Description and Major Businesses
Table 132. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Techwell Follicle Stimulating Hormone Product
Table 134. Techwell Recent Developments
Table 135. GenSci Corporation Information
Table 136. GenSci Description and Major Businesses
Table 137. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. GenSci Follicle Stimulating Hormone Product
Table 139. GenSci Recent Developments
Table 140. Gedeon Richter Corporation Information
Table 141. Gedeon Richter Description and Major Businesses
Table 142. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Gedeon Richter Follicle Stimulating Hormone Product
Table 144. Gedeon Richter Recent Developments
Table 145. Teva Corporation Information
Table 146. Teva Description and Major Businesses
Table 147. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. Teva Follicle Stimulating Hormone Product
Table 149. Teva Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Follicle Stimulating Hormone Distributors List
Table 153. Follicle Stimulating Hormone Customers List
Table 154. Follicle Stimulating Hormone Market Trends
Table 155. Follicle Stimulating Hormone Market Drivers
Table 156. Follicle Stimulating Hormone Market Challenges
Table 157. Follicle Stimulating Hormone Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicle Stimulating Hormone Product Picture
Figure 2. Global Follicle Stimulating Hormone Market Share by Type in 2020 & 2027
Figure 3. Recombinant FSH Product Picture
Figure 4. Urinary FSH Product Picture
Figure 5. Global Follicle Stimulating Hormone Sales Market Share by Application in 2020 & 2027
Figure 6. Infertility Treatment
Figure 7. Assisted Reproductive Technology
Figure 8. Follicle Stimulating Hormone Report Years Considered
Figure 9. Global Follicle Stimulating Hormone Sales 2016-2027 (K Doses)
Figure 10. Global Follicle Stimulating Hormone Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Follicle Stimulating Hormone Revenue 2016-2027 (US$ Million)
Figure 12. Global Follicle Stimulating Hormone Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Figure 14. Global Follicle Stimulating Hormone Sales Market Share by Region (2022-2027)
Figure 15. North America Follicle Stimulating Hormone Sales YoY (2016-2027) & (K Doses)
Figure 16. North America Follicle Stimulating Hormone Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Follicle Stimulating Hormone Sales YoY (2016-2027) & (K Doses)
Figure 18. Europe Follicle Stimulating Hormone Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Follicle Stimulating Hormone Sales YoY (2016-2027) & (K Doses)
Figure 20. Asia-Pacific Follicle Stimulating Hormone Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Follicle Stimulating Hormone Sales YoY (2016-2027) & (K Doses)
Figure 22. Latin America Follicle Stimulating Hormone Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Follicle Stimulating Hormone Sales YoY (2016-2027) & (K Doses)
Figure 24. Middle East & Africa Follicle Stimulating Hormone Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Follicle Stimulating Hormone Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Follicle Stimulating Hormone Revenue in 2020
Figure 27. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 29. Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 30. Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 31. Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 32. North America Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 33. North America Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 34. North America Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 35. North America Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 36. North America Follicle Stimulating Hormone Sales Share by Country (2016-2027)
Figure 37. North America Follicle Stimulating Hormone Revenue Share by Country (2016-2027)
Figure 38. Europe Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 39. Europe Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 40. Europe Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 41. Europe Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 42. Europe Follicle Stimulating Hormone Sales Share by Country (2016-2027)
Figure 43. Europe Follicle Stimulating Hormone Revenue Share by Country (2016-2027)
Figure 44. Poland Follicle Stimulating Hormone Revenue (2016-2027) & (US$ Million)
Figure 45. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 46. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 47. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 48. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 49. Asia Pacific Follicle Stimulating Hormone Sales Share by Region (2016-2027)
Figure 50. Asia Pacific Follicle Stimulating Hormone Revenue Share by Region (2016-2027)
Figure 51. Latin America Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 52. Latin America Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 53. Latin America Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 54. Latin America Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 55. Latin America Follicle Stimulating Hormone Sales Share by Country (2016-2027)
Figure 56. Latin America Follicle Stimulating Hormone Revenue Share by Country (2016-2027)
Figure 57. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Type (2016-2027)
Figure 58. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Type (2016-2027)
Figure 59. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Application (2016-2027)
Figure 60. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Application (2016-2027)
Figure 61. Middle East and Africa Follicle Stimulating Hormone Sales Share by Country (2016-2027)
Figure 62. Middle East and Africa Follicle Stimulating Hormone Revenue Share by Country (2016-2027)
Figure 63. Follicle Stimulating Hormone Value Chain
Figure 64. Follicle Stimulating Hormone Production Process
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Bott

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs